My PhD thesis focusses on the generation of cell-based cancer vaccines and their improvement through genetic modulation.
After a Bachelor’s of Science and Master’s in Medical Biology at the University of Lausanne, I worked as an intern at the University of Oxford. I joined the lab of Pr Pedro Romero at the Department of oncology UNIL CHUV as a lab technician before starting my PhD in the laboratory of Pr Lana Kandalaft in 2018.
My current research interests focus on: i) investigating the impact and mechanisms of HOCl in improving the immunogenicity of cancer antigens; ii) developing a novel platform and pipeline for a therapeutic cancer vaccine and iii) identifying immunomodulatory effects of key metabolites and their impact on the therapeutic efficacy of DC-based cancer vaccines.
I hold a Bachelor’s in Chemistry from the University of Padua and a Master’s in Chemistry of Biological Systems from the University of La Sapienza, Rome. I received a PhD in Cell Physiology and Pharmacology from the University of Leicester studying P. falciparum kinases as novel drug targets against malaria. I was also a postdoctoral researcher at EPFL, the Swiss Federal Institute of Technology, Lausanne conducting a high-throughput screening aimed at identifying novel modulators of centriole duplication and cancer cell division.
My project focuses on studying different personalized vaccination strategies in various mouse models and how to improve their efficacy.
My interest is in advanced science capable of improving our patients’ lives.
I did my apprenticeship as a laboratory technician at Novartis. Prior to joining the Department of oncology UNIL CHUV, I worked for five years on research into blood cancers at the Inselspital in Bern.
I am currently in charge of pre-clinical and clinical projects investigating the immunological signatures of interventional radiology treatments in cancer, with an aim of expanding the IR’s applicative horizons beyond local therapies.
I hold a PhD in Cancer Biology from the University of Zurich, and have a decade of experience in the fields of cellular immunology and hematology.
Ludwig adjunct scientist
Laboratory L. Kandalaft
Department of oncology UNIL CHUV
Ludwig Institute for Cancer Research Lausanne
Director of Center of experimental therapeutics, Lausanne University Hospital (CHUV)
Phone +41 21 314 78 23
Fax +41 21 314 10 33
AGORA Cancer Research Centre
Rue du Bugnon 25A